Quantcast

Latest lung cancer Stories

2014-05-14 16:28:52

This early phase study also evaluated an abemaciclib combination in hormone receptor positive metastatic breast cancer patients INDIANAPOLIS, May 14, 2014 /PRNewswire/ -- Abemaciclib, an oral drug administered twice daily, currently in development by Eli Lilly and Company (NYSE: LLY), has shown evidence of single-agent activity in patients with advanced non-small cell lung cancer in a Phase I study released ahead of the American Society of Clinical Oncology (ASCO) Annual Meeting to...

2014-05-13 16:28:15

Lung Cancer Became the Leading Cause of Cancer Death Among Women in the 1980's WASHINGTON, May 13, 2014 /PRNewswire-USNewswire/ -- Lung Cancer Alliance praised American Lung Association on its launch of LUNG FORCE, an initiative aimed at raising awareness among women about lung cancer. "We welcome the American Lung Association's help in bringing attention to the fact that lung cancer is the leading cause of cancer death among women - an appropriate and important message during...

2014-05-13 08:31:14

CVS Caremark signs on as national presenting sponsor to raise awareness of the #1 cancer killer of women CHICAGO, May 13, 2014 /PRNewswire/ -- Today, the American Lung Association, in partnership with national presenting sponsor, CVS Caremark, unveiled LUNG FORCE, a new initiative to make lung cancer in women a public health priority, drive policy change and increase research funding. To view the multimedia assets associated with this release, please click:...

2014-05-09 23:04:46

Markets Research Reports.biz added deep and professional market research reports on "Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2014" analysis and overview. (PRWEB) May 09, 2014 Small-Cell Lung Cancer Global Clinical Trials Review, H1, 2014 provides data on the Small-Cell Lung Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Small-Cell Lung Cancer. It includes an overview of the trial numbers...

2014-05-09 19:06:35

Massachusetts Institute of Technology Nanoparticles that stagger delivery of 2 drugs knock out aggressive tumors in mice MIT researchers have devised a novel cancer treatment that destroys tumor cells by first disarming their defenses, then hitting them with a lethal dose of DNA damage. In studies with mice, the research team showed that this one-two punch, which relies on a nanoparticle that carries two drugs and releases them at different times, dramatically shrinks lung and breast...

2014-05-08 08:33:07

Clinicians detail how the Edge(TM) radiosurgery suite and other cancer treatment technologies from Varian Medical Systems are enabling fast, precise tumor targeting MINNEAPOLIS, May 8, 2014 /PRNewswire/ -- Radiation oncologists and a neurosurgeon from noted institutions in the U.S. and Europe report that they are able to use non-invasive radiosurgery to treat a widening variety of cancers due to technology advances that are making it possible to deliver these treatments more quickly...

2014-05-06 16:33:11

Hope Summit and New Scientific Grant Applications Kick Off Lung Cancer Hope Month WASHINGTON, May 6, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation, the nation's leading lung cancer nonprofit, commemorates May, Lung Cancer Hope Month, as a time to celebrate the hope and promise of science in the ongoing quest for a world where no one dies from lung cancer. LUNGevity Foundation President and CEO Andrea Stern Ferris noted the remarkable progress in lung cancer treatments, growth of lung...

2014-05-05 20:25:53

LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Molecular Diagnostics in Cancer Testinghttp://www.reportbuyer.com/pharma_healthcare/diagnostics/molecular_diagnostics_cancer_testing.htmlMolecular diagnostics is a rapidly-advancing area of research and medicine, with new technologies and applications being continually added. The technologies that come under the umbrella of molecular diagnostics include first-generation amplification, DNA...

2014-05-05 08:29:46

SAN DIEGO, May 5, 2014 /PRNewswire/ -- MEI Pharma, Inc. (Nasdaq: MEIP), an oncology company focused on the clinical development of novel therapies for cancer, announced today that the first patient has been dosed in a Phase Ib clinical study of its investigational mitochondrial inhibitor drug candidate ME-344 in combination with Hycamtin(®) (topotecan) in patients with solid tumors, including small cell lung and ovarian cancers. The open-label study is expected to enroll up to 64...

2014-05-02 16:24:22

Medicare Committee Decision Leaves Medicare-Reliant At Risk WASHINGTON, May 2, 2014 /PRNewswire-USNewswire/ -- LUNGevity Foundation President Andrea Ferris today commented on the Medicare panel decision against funding for CT scans. Ms. Ferris said, "LUNGevity Foundation is disappointed in the Medicare Evidence & Coverage Advisory Committee (MEDCAC) decision against covering annual CT scans to detect lung cancer in a high risk population. The results of the National Lung Cancer Screening...


Latest lung cancer Reference Libraries

Clinical Lung Cancer
2012-05-14 11:09:55

Clinical Lung Cancer is a peer-reviewed medical journal published bimonthly by the CIG Media Group. It was established in 1999. As of May 2012, the editor-in-chief is David R. Gandara. Gandara is a member of the Board of Directors of the International Association for the Study of Lung Cancer and the Addario Foundation. He has also served as a member of the Board of Directors of the American Society of Clinical Oncology (ASCO) and as secretary-treasurer. He is furthermore a member of...

More Articles (1 articles) »
Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related